Filter
716
Text search:
drug
dosing
Featured
Recommendations
102
New Publications
195
Language
Document type
No document type
418
Guidelines
153
Studies & Reports
76
Manuals
24
Training Material
15
Fact sheets
13
Strategic & Response Plan
10
Situation Updates
3
Resource Platforms
2
App
1
Online Courses
1
Countries / Regions
India
45
South Africa
33
Kenya
23
Tanzania
21
Ethiopia
17
Global
15
Zambia
14
Uganda
10
Nepal
10
Africa
10
Rwanda
9
Ghana
8
Namibia
8
Sierra Leone
7
Nigeria
7
Malawi
7
Western and Central Europe
7
Zimbabwe
6
Bangladesh
6
Myanmar / Burma
6
Philippines
5
Liberia
4
USA
4
Cambodia
4
South Sudan
3
Eswatini/ Swaziland
3
Lesotho
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
2
Syria
2
Argentina
2
Ukraine
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Burkina Faso
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Germany
1
Gambia
1
Indonesia
1
Sudan
1
Benin
1
Brazil
1
Botswana
1
Angola
1
East and Southern Africa
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
242
Clinical Guidelines
146
Women & Child Health
40
Public Health
24
Capacity Building
20
Key Resources
3
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
108
TB
85
AMR
62
Pharmacy
34
Mental Health
32
COVID-19
24
NCDs
20
NTDs
17
Caregiver
11
Ebola
8
Conflict
6
Rapid Response
5
Refugee
5
Cholera
4
Planetary Health
3
Polio
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Bridging the Gap
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
The target audience for this guideline is primarily for health care providers nurses, doctors, social workers and other people involved in HIV response in Rwanda so that they are capable of offering quality care services to patients over a long time. The new National Guidelines for Prevention and Ma
...
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for
...
WHO recommendations on child health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med
...
S Afr Med J 2018;108(7):546-550. DOI:10.7196/SAMJ.2018.v108i7.13149
Antimicrobial stewardship programmes have been introduced worldwide in response to the rise in antimicrobial resistance. The World Health Organization has mandated each Member State to produce a plan to address this problem. We rep
...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re
...
Moving from accelerated burden reduction to malaria elimination in Zambia
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
Module: Disorders due to substance abuse mhGAP
recommended
Accessed: 21.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
